Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 42

Results For "UPI"

510 News Found

Lupin launches penicillamine tablets USP
News | March 04, 2021

Lupin launches penicillamine tablets USP

Penicillamine Tablets USP, 250 mg (RLD: Depen) had estimated annual sales of USD 5 million in the U.S. (IQVIA MAT December 2020).


Lupin receives approval for Droxidopa capsules
News | February 20, 2021

Lupin receives approval for Droxidopa capsules

Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness


Lupin launches posaconazole delayed-release tablets
News | February 18, 2021

Lupin launches posaconazole delayed-release tablets

posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.


LupinLife Launches ayurvedic energy supplement
News | February 12, 2021

LupinLife Launches ayurvedic energy supplement

Be One is a 100% Ayurvedic health and wellness supplement.


Lupin receives approval for tavaborole topical solution
News | February 10, 2021

Lupin receives approval for tavaborole topical solution

Tavaborole Topical Solution, 5%, is an oxaborole antifungal.


India’s opportunity to build preventive healthcare economy
Opinion | May 19, 2026

India’s opportunity to build preventive healthcare economy

The country’s strength lies not just in technology availability but in adoption behaviour


Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion
Hospitals | May 18, 2026

Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion

Medanta expanded its bed capacity by 20% during the year


LVPEI hosts 8th Whitathon to raise awareness on childhood eye cancer
Hospitals | May 11, 2026

LVPEI hosts 8th Whitathon to raise awareness on childhood eye cancer

Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week


Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%
Hospitals | May 09, 2026

Artemis Medicare Q4 FY26 revenue rises 16.4% to Rs. 27,923 lakh, net profit jumps 32.1%

The hospital chain reported strong growth driven by its Gurugram facility, international patient inflow, and operational efficiencies


NIFTY Pharma remains resilient amid mixed market sentiment
News | May 05, 2026

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures